Micronized progesterone: Clinical Trials

7 trials of Micronized progesterone, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 unknown, 1 terminated. 7 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 27Completed 4, Unknown 2, Terminated 1
Phase 11Terminated 1

Follow Micronized progesterone: new trials by email Literature Review of Micronized progesterone trials Research Report on Micronized progesterone

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Neurobiology of Bulimia Nervosa
Estradiol, Micronized progesterone, Leuprolide Acetate - Bulimia Nervosa
Phase 2CompletedUniversity of North Carolina, Chapel Hill102020-02-242022-07-26
Characterizing the Neural Substrates of Irritability in Women: an Experimental Neuroendocrine Model
Leuprolide Acetate 3.75 MG/ML, Estradiol 2 Mg tablet, Micronized progesterone - Perinatal Depression, Post Partum Depression
Phase 2CompletedUniversity of North Carolina, Chapel Hill232020-01-022023-08-25
Follicle Stimulating Hormone (FSH) Glycosylation in Women: Effect of Estradiol
Estradiol Transdermal Product - Follicle Stimulating Hormone Glycosylation, Urinary FSH21/FSH24 Ratio
Phase 2UnknownEastern Virginia Medical School102019-07-032019-07-12
Blocking Mifepristone Action With Progesterone
Mifepristone 200 MG, micronized Progesterone, Placebo oral capsule - Pregnancy, Unwanted
Phase 1 / Phase 2TerminatedUniversity of California, Davis122019-02-112020-01-22
Luteal Phase Estradiol Support for In Vitro Fertilization/Intracytoplasmic Sperm Injection Cycles
17-beta estradiol, Micronized progesterone - IVF
Phase 2UnknownOne Fertility5062016-05-012016-02-10
A Trial to Evaluate DR-2021 in Women With Secondary Amenorrhea
DR-2021a, DR-2021b, DR-2021c - Amenorrhea
Phase 2CompletedDuramed Research1802005-09-012014-07-30
Progesterone Treatment in Female Smokers - 12
Micronized Progesterone - Tobacco Use Disorder
Phase 2CompletedNational Institute on Drug Abuse (NIDA)1999-04-012017-01-12

Conditions studied

Amenorrhea (1)  ·  Bulimia (1)  ·  Bulimia Nervosa (1)  ·  Depression (1)  ·  Depression, Postpartum (1)  ·  Feeding and Eating Disorders (1)  ·  Mental Disorders (1)  ·  Mood Disorders (1)  ·  Tobacco Use Disorder (1)

Sponsors

University of North Carolina, Chapel Hill (2)  ·  Duramed Research (1)  ·  Eastern Virginia Medical School (1)  ·  National Institute on Drug Abuse (NIDA) (1)  ·  One Fertility (1)  ·  University of California, Davis (1)

Countries

United States (6)

Top investigators

Crystal E Schiller, PhD (1)  ·  Dorothy Hatsukami, Ph.D. (1)  ·  Jessica Baker, PhD (1)  ·  Mitchell D Creinin, MD (1)

Results publications

PMID 31809439

NIH funding

R21MH119615 (1), R21MH121726 (1)